Reduced levels of the adenomatous polyposis coli (APC) protein are associated with ceramide-induced apoptosis of colon cancer cells

Journal of Cancer Research and Clinical Oncology
Aruna S Jaiswal, Satya Narayan

Abstract

Mutations of the adenomatous polyposis coli (APC) and p53 genes are commonly found in colorectal cancers. We therefore analyzed the relative roles of APC and p53 in the induction of apoptosis of colon cancer cells by comparing the effects of the natural chemopreventive agent, C(2)-ceramide, on different human colon cancer cell lines with and without wild-type p53 and APC genes. We studied the effect of C(2)-ceramide and C(2)-dihydroceramide on proliferation and/or apoptosis of colon cancer cell lines in vitro and determined the role of p53 and APC proteins in these processes. The protein and mRNA levels in colon cancer cell lines with and without treatments were determined by Western and Northern blot analysis, respectively. The cell cycle and apoptosis profiles were determined by FACS analysis and PARP-1 cleavage. Our findings indicate that C(2)-ceramide can induce apoptosis independently of the p53/p21(Waf-1/Cip-1) pathway. In addition, the C(2)-ceramide induction of apoptosis showed a correlation with a reduction in the levels of the APC protein and mRNA. Moreover, the C(2)-ceramide-induced apoptosis was blocked by pre-treatment with ZnCl(2), which stabilizes APC protein levels. These results suggest that C(2)-ceramide treat...Continue Reading

References

May 1, 1994·The Journal of Nutrition·D L DillehayA H Merrill
Mar 19, 1993·Science·L M ObeidY A Hannun
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·P J MorinK W Kinzler
Dec 1, 1996·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·G J KelloffC C Sigman
Jun 1, 1997·The Journal of Nutrition·P W Parodi
Aug 22, 1997·The Journal of Biological Chemistry·J W KokA H Merrill
Jan 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·T A ChanK W Kinzler
Jun 11, 1998·The Biochemical Journal·R J VeldmanJ W Kok
Apr 29, 1998·Annual Review of Physiology·R N Kolesnick, M Krönke
Jul 24, 1998·Biotherapy·B N Ames, L S Gold
Jul 8, 1999·The Journal of Nutrition·H VesperA H Merrill
Aug 3, 1999·The Journal of Clinical Investigation·F BunzB Vogelstein
Sep 10, 1999·The Journal of Biological Chemistry·Y YamamotoR B Gaynor
Apr 6, 2000·The Journal of Biological Chemistry·M Rezvani, C C Liew
Jul 27, 2000·Journal of Cellular Physiology·R N KolesnickA Alonso
Oct 21, 2000·The Oncologist·W C Willett
Feb 13, 2001·The Journal of Clinical Investigation·Y Yamamoto, R B Gaynor
Mar 10, 2001·Experimental Cell Research·J H van EsH C Clevers
Mar 21, 2001·Human Molecular Genetics·N S FearnheadW F Bodmer
Jan 5, 2002·Proceedings of the National Academy of Sciences of the United States of America·Sumitaka HasegawaTetsuo Noda
Jan 25, 2002·Annual Review of Pharmacology and Toxicology·Lawrence J Marnett, Raymond N DuBois
Mar 15, 2002·International Journal of Oncology·David ChauvierMichel Manfait
Apr 12, 2002·Current Pharmaceutical Design·Masanobu Oshima, Makoto M Taketo
Apr 25, 2002·The Journal of Biological Chemistry·Shashi Prajapati, Richard B Gaynor
Apr 27, 2002·Experimental Biology and Medicine·Eun Hyun Ahn, Joseph J Schroeder
May 2, 2002·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·B BerraA Giacosa
May 4, 2002·Nature Reviews. Molecular Cell Biology·Mariann Bienz
Jun 14, 2002·Seminars in Oncology·Minetta C Liu, Edward P Gelmann
Jul 3, 2002·The Journal of Clinical Investigation·Richard Kolesnick
Aug 3, 2002·Nature Reviews. Cancer·Karen H Vousden, Xin Lu
Sep 6, 2002·Biochemical Pharmacology·Moshe OrenAvri Ben-Ze'ev
Sep 28, 2002·Mutation Research·Rashmi Sinha
Nov 30, 2002·Journal of Cancer Research and Clinical Oncology·Y KishimotoJ Hasegawa
Dec 18, 2002·Annals of the New York Academy of Sciences·Moshe OrenAvri Ben-Ze'Ev
Sep 16, 2004·Journal of Cellular Biochemistry·Aruna S Jaiswal, Satya Narayan

❮ Previous
Next ❯

Citations

Sep 26, 2013·Biochimica Et Biophysica Acta·Mónica García-BarrosYusuf A Hannun
Jul 11, 2021·Cellular Signalling·Real Sumayya Abdul SattarSundeep Singh Saluja

❮ Previous
Next ❯

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.